Literature DB >> 7926455

Localization of cholecystokinin A and cholecystokinin B/gastrin receptors in the canine upper gastrointestinal tract.

C R Mantyh1, T N Pappas, S R Vigna.   

Abstract

BACKGROUND/AIMS: Cholecystokinin (CCK) is a neuropeptide that exerts numerous effects in the gut. To determine the sites of action of CCK, the distribution and properties of CCK receptor subtypes were studied.
METHODS: CCK receptors were localized by autoradiographic analysis of 125I-CCK binding to frozen sections of the canine upper gastrointestinal tract.
RESULTS: In the cardiac and fundic stomach, CCK-B/gastrin receptors were found in the mucosa and in a subpopulation of neuronal elements in the circular muscle. The antrum expressed CCK-B/gastrin receptors in a few neurons in the circular muscle and in the entire myenteric plexus; no receptors were observed in the antral mucosa or esophagus. The duodenum showed a high concentration of CCK-B/gastrin receptors in the myenteric plexus. The cardiac and fundic basal mucosae expressed CCK-A receptors. Two nonpeptide CCK receptor antagonists were unable to differentiate between the receptor subtypes.
CONCLUSIONS: The differential expression of CCK receptor subtypes in the gastric mucosa provides a morphological basis for the separate regulatory roles of CCK and gastrin in gastric function. CCK-B/gastrin receptor expression in a subset of neurons in gastric circular muscle suggests a novel site of action for CCK and/or gastrin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926455     DOI: 10.1016/0016-5085(94)90226-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Intestinal transit of fat depends on accelerating effect of cholecystokinin and slowing effect of an opioid pathway.

Authors:  Henry C Lin; Oren Zaidel; Susan Hum
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  Molecular cloning, expression and pharmacological characterization of the canine cholecystokinin 1 receptor.

Authors:  Magda Francesca Morton; Jayashree Pyati; Heng Dai; Lina Li; Veronica Moreno; Nigel Paul Shankley
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.

Authors:  Mingao Wang; Rujuan Xie; Ruichan Liu; Xibei Jia; Yushi Bao; Xiaomin Liu
Journal:  Endocrine       Date:  2012-03-07       Impact factor: 3.633

Review 4.  The gut and food intake: an update for surgeons.

Authors:  E Näslund; P M Hellström; J G Kral
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

5.  Pseudopod-like basal cell processes in intestinal cholecystokinin cells.

Authors:  Rashmi Chandra; Leigh Ann Samsa; Steven R Vigna; Rodger A Liddle
Journal:  Cell Tissue Res       Date:  2010-06-26       Impact factor: 5.249

6.  Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.

Authors:  Y Zavros; A Shulkes
Journal:  J Physiol       Date:  1997-12-15       Impact factor: 5.182

Review 7.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

8.  Cellular and subcellular localization of cholecystokinin (CCK)-1 receptors in the pancreas, gallbladder, and stomach of mice.

Authors:  Kohtarou Konno; Hiromi Takahashi-Iwanaga; Motokazu Uchigashima; Kyoko Miyasaka; Akihiro Funakoshi; Masahiko Watanabe; Toshihiko Iwanaga
Journal:  Histochem Cell Biol       Date:  2014-09-24       Impact factor: 4.304

Review 9.  CCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disorders.

Authors:  R T Jensen
Journal:  Yale J Biol Med       Date:  1996 May-Jun

10.  Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo.

Authors:  H Louise Ashurst; Andrea Varro; Rod Dimaline
Journal:  Exp Physiol       Date:  2007-10-12       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.